[Survival and prognostic factors in radiation and combination therapy of bone metastases of breast cancer].
A retrospective analysis of the survival and mean life rates of 107 patients with breast cancer metastases to the skeletal bones was performed. In non-randomized groups there was no significant correlation of long-term therapeutic results and the type of fractionation, a total radiation dose value, chemo- or hormonotherapy. Prognosis was better in patients in whom solitary metastases were detected 5 and more years after primary treatment. In such cases radiation therapy was indicated at doses sufficient for eradication or stable stabilization of a focus using the most sparing dose fractionation regimens.
Shcherbenko
O I
OI
D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary* / Q000628:therapy; D001943:Breast Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011379:Prognosis; D012189:Retrospective Studies
Vyzhivaemost' i faktory prognoza pri luchevom i kompleksnom lechenii metastazov raka molochnoĭ zhelezy v kosti.